Jessica Gibson

Jessica M. Gibson, MBA

Chief Executive Officer

Ms. Gibson has a BS in Emergency Medicine from University of Pittsburgh, an Executive MBA and has held multiple leadership positions within the healthcare industry. She has experience in both laboratory (published in Critical Care Medicine) and clinical practice as well as in biotechnology working with Genewiz developing strategic relationships for genetic research services. She has been the national sales representative for two pharmaceutical companies (Shionogi-formerly Sciele, and Purdue Pharma) and has successfully launched various products into national competitive medical fields and managed multiple business territories.

Mark Haupt, MD

Mark Haupt, MD

Chief Medical Officer

Dr. Haupt earned a BA with honors from Amherst College​ and his MD from the Northwestern Feinberg School of Medicine. He is a University of Chicago and Northwestern trained Pediatric Pulmonologist. His research focus was cystic fibrosis, specifically examining epidemiological data to evaluate nutritional outcomes. After completing training, Dr. Haupt joined AbbVie, quickly accelerating from their Physician Professional Development Program to a leadership role in the US Medical Affairs organization and earning a President's Award. Dr. Haupt joined ARIEL in 2016.

Tory Moore

John "Tory" Moore, CFA

Chief Financial Officer

Mr. Moore earned a BS in economics from Trinity College and was elected to Pi Gamma Mu, the international social sciences honors society. After several years in the investment management industry, he matriculated to the University of Michigan's Ross School of Business where he earned an MBA. After graduating in 2012, he launched a hedge fund with capital raised from friends and family, and he began assisting Blue Tree Allied Angels with due diligence of early stage companies. Excited by working with local startups, Mr. Moore joined the Ariel team in 2015.

Jessica LaRusch

Jessica LaRusch, Ph.D.

Lead Genetic Scientist

Dr. LaRusch is an expert in genetics, molecular biology and bioinformatics, the lead geneticist in the largest genetic study of pancreatitis in North America, and contributor to the CFTR2.org database, the first comprehensive clinical and functional reference site for all known mutations in CFTR, the gene mutated in cystic fibrosis.